XVIVO

Founded in 1998, XVIVO’s innovative technologies enable clinicians and researchers around the world to preserve, transport and assess organs outside the body. XVIVO has more than 160 employees, with products sold in about 90 countries. Their pioneering technologies have been clinically proven to increase utilization of donated organs and improve transplantation outcomes. The XVIVO XPS system is known for its high level of precision and reliability in ex vivo lung perfusion and ventilation. This makes the system highly adaptable and effective across various transplant centres worldwide, enabling personalized management of the donor organ.